Skip to main content
. 2020 Aug 26;50(5):1380–1386. doi: 10.3906/sag-2003-93

Table 3.

Responses of the patients during follow-up.

Initial 1st monthfollow-up 3rd monthfollow-up 6th monthfollow-up
Palpable mass, n (%) 53 (100) 1 (1.9) 5 (9.4) 19 (35.8)
Skin changes, n (%) 38 (71.7) 1 (1.9) 5 (9.4) 4 (7.5)
Ulceration, n (%) 11 (20.8) 0 0 0
Fistula formation and purulent drainage, n (%) 30 (56.5) 1 (1.9) 1 (1.9) 0
Diameter of mass, mean ± SD 2.5 ± 1.0 1.2 ± 0.5 0.5 ± 0.3